Viral Pathogenesis

The portal of entry is the specific route by which a virus first enters the host. The major portals are the respiratory tract (influenza, measles, and the broader respiratory virus group), the gastrointestinal tract (the enteric viruses), the genitourinary tract (HIV, HSV-2, HPV), skin or mucous membrane breach (HSV, some arboviruses via arthropod bite), and the parenteral or bloodborne route (HIV, hepatitis B, hepatitis C).

The portal of entry determines the initial site of viral replication and, in many cases, strongly predicts the ultimate clinical syndrome. For viruses capable of subsequent dissemination, the disease produced can be far removed anatomically from the original portal of entry.

Local replication is initial viral replication at or near the portal of entry, within cells bearing the appropriate receptor for the infecting virus. For many viruses, this local replication phase alone is sufficient to produce disease confined to the entry site, as seen in most respiratory and enteric viral infections. For others, local replication serves as the launching point for subsequent systemic spread.

Primary viraemia is the initial appearance of virus in the bloodstream following local replication at the portal of entry. It typically produces a low-level, often clinically silent or minimally symptomatic viraemic phase. The virus is disseminated via the blood to reach secondary target organs, where a second, more extensive round of replication then occurs.

Secondary viraemia is a larger-magnitude, more sustained viraemic phase following replication at the secondary target organs reached during primary viraemia. It typically corresponds to the onset of the clinically apparent, symptomatic phase of a systemically disseminating viral illness.

This two-phase primary and secondary viraemia pattern is classically illustrated by several exanthematous childhood viral infections, measles being the paradigm example. An initial respiratory-tract entry and local replication phase is followed by primary viraemia disseminating the virus to the reticuloendothelial system.

Replication there produces secondary viraemia, which then delivers virus to the skin and other target organs, producing the characteristic rash and other systemic manifestations that mark the clinically recognisable onset of illness, often only after this multi-step sequence has already been underway for days.

Tissue tropism is the specific tissue a virus preferentially infects, determined predominantly by host cell receptor distribution. It is the single strongest predictor of ultimate clinical disease pattern in virology as a whole.

Cell injury describes the mechanisms by which viral infection damages the host cell. The balance between direct viral cytopathic effect and host immune-mediated damage varies substantially by virus and is a recurring theme when comparing pathogenesis across different virus families.

Immune mediated damage is tissue injury resulting not from direct viral cytotoxicity but from the host's own immune response to infection. This mechanism is of major importance across many viral diseases, and it directly parallels the immune-mediated post-infectious complications seen with several bacterial pathogens, such as rheumatic fever following Streptococcus pyogenes or Guillain-Barre syndrome following Campylobacter.

Cytotoxic T lymphocytes, in the process of recognising and destroying virus-infected cells, directly contribute to tissue damage even though this same T cell response is simultaneously essential for viral clearance. This double-edged mechanism recurs across viral hepatitis, where much of the liver cell damage in hepatitis B specifically is considered immune-mediated rather than a direct consequence of viral cytopathic effect, and in several other conditions.

Immune complex deposition, antibody bound to viral antigen depositing in tissue and triggering complement-mediated inflammation, is a further immune-mediated mechanism, relevant to specific complications of some viral infections, such as the glomerulonephritis occasionally associated with chronic hepatitis B and hepatitis C infection.

Persistent infection is an infection in which the virus is not fully cleared by the host immune response but instead continues, in some active form, for a prolonged period, potentially for the remainder of the host's life.

Latency is a specific form of persistent infection in which the viral genome remains present within host cells in a largely or entirely transcriptionally silent state, producing no infectious virions and no active disease, but retaining the capacity to reactivate. The herpesvirus family is the paradigm example, with latency established in a specific, characteristic cell type for each individual herpesvirus.

Reactivation is the re-emergence of active viral replication from a previously established latent state, typically triggered by a decline in host immune surveillance, such as stress, intercurrent illness, immunosuppression, or advancing age, or, for some viruses, by other specific local or systemic triggers. This is the mechanistic basis of shingles, VZV reactivation from dorsal root ganglion latency, recurrent herpes labialis and genitalis, HSV reactivation from sensory ganglion latency, and CMV reactivation disease in immunocompromised hosts.

Oncogenesis is the capacity of certain viruses to directly or indirectly contribute to malignant transformation of infected host cells. It is one of several possible long-term outcomes of viral infection, alongside clearance, persistence, latency with reactivation, and chronic ongoing tissue damage.

Cell lysis is direct rupture of the host cell as newly assembled virions accumulate beyond the cell's structural capacity, particularly characteristic of nonenveloped viruses, which lack a budding release mechanism and must therefore lyse the cell to escape. This is the direct structural basis of the cytopathic effects historically used to detect viral growth in cell culture.

Inhibition of host synthesis describes the active suppression of host cell macromolecular synthesis, transcription, translation, or both, seen in many viral infections. This redirects the host cell's machinery preferentially toward viral protein production, and for some viruses functions as a specific immune evasion strategy by suppressing synthesis of host antiviral proteins. This global shutdown of normal host cell function contributes directly to cell injury and death independent of any structural damage from virion assembly or release itself.

Syncytium formation occurs when a virus expresses fusion-competent envelope glycoproteins on the surface of an infected cell, causing that cell to fuse with adjacent uninfected cells bearing the appropriate receptor and producing a large, multinucleated giant cell called a syncytium. Paramyxoviruses, including measles and respiratory syncytial virus, and HIV are notable examples of this mechanism.

It allows the virus to spread directly from cell to cell without ever being exposed to the extracellular environment, evading circulating neutralising antibody entirely during this mode of spread, and it is a classic histopathological finding on tissue biopsy or cytology, with multinucleated giant cells a specific and recognised finding in measles-infected and herpesvirus-infected tissue, among others.

Apoptosis, programmed cell death, can be directly triggered by viral infection itself, since some viruses actively induce host cell apoptosis as part of their replication or release strategy, or it can represent a host cell defence mechanism, triggering its own controlled death specifically to limit viral replication and spread before large numbers of progeny virions can be produced. Some viruses in turn actively counteract this host-defensive apoptosis by expressing specific anti-apoptotic proteins.

Immune destruction of infected cells refers to cytotoxic T lymphocyte recognition and killing of virus-infected cells, via recognition of viral peptide presented on host MHC class I. This is simultaneously the principal mechanism of viral clearance and a direct cause of tissue injury, since the T cell response destroys host tissue along with the virus it contains, a genuinely inseparable dual consequence recurring throughout viral pathogenesis.